Kurt Krapfenbauer

TL;DR: A series of interpretative and practical issues that need to be understood and resolved before potential biomarkers become a clinically approved test or are already on the diagnostic market are discussed.

TL;DR: The dedicated EPMA working group provides a deep analysis in the issue followed by the expert recommendations considering the multifaceted aspects of both “disease care” and “health care’ practices including ethics and economy, life quality of individuals and patients, interests of professional groups involved, benefits of subpopulations, health care system(s) and society as a whole.

TL;DR: The findings of this pilot study show that OSCC gene ontology combined with proteomic analysis is a powerful tool in systems biology for the elucidation of the complexity of expression profiles in cellular processes and could significantly contribute to the efficient performance of the entire discovery process.

TL;DR: Few examples of drug treatment in MDR in diabetes mellitus associated with function of ABC-transporters are presented and the physiological role of these transporters to MDR is not yet fully understood.

TL;DR: In order to minimise possible variations, saliva from five patients without squamous cell carcinoma pathology and five with suspicion of oral squamous carcinoma (OSCC) were collected and matched at different days and analysed by two-dimensional polyacrylamide gel electrophoresis (2DE-PAGE).